Nuveen Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-329,146
| Closed | -$10.9M | – | 3176 |
|
|
2022
Q4 | $10.9M | Sell |
329,146
-103,682
| -24% | -$3.44M | ﹤0.01% | 1430 |
|
|
2022
Q3 | $13.6M | Buy |
432,828
+3,788
| +0.9% | +$119K | 0.01% | 1284 |
|
|
2022
Q2 | $13.1M | Buy |
429,040
+180,951
| +73% | +$5.5M | 0.01% | 1341 |
|
|
2022
Q1 | $6.24M | Sell |
248,089
-135,569
| -35% | -$3.41M | ﹤0.01% | 1942 |
|
|
2021
Q4 | $7.83M | Sell |
383,658
-184,311
| -32% | -$3.76M | ﹤0.01% | 1834 |
|
|
2021
Q3 | $10.9M | Sell |
567,969
-112,002
| -16% | -$2.15M | ﹤0.01% | 1715 |
|
|
2021
Q2 | $15.1M | Buy |
679,971
+48,778
| +8% | +$1.08M | ﹤0.01% | 1587 |
|
|
2021
Q1 | $16.6M | Sell |
631,193
-9,134
| -1% | -$240K | 0.01% | 1460 |
|
|
2020
Q4 | $12M | Sell |
640,327
-196,954
| -24% | -$3.68M | ﹤0.01% | 1587 |
|
|
2020
Q3 | $14.2M | Sell |
837,281
-129,507
| -13% | -$2.2M | 0.01% | 1271 |
|
|
2020
Q2 | $22.5M | Buy |
966,788
+201,885
| +26% | +$4.7M | 0.01% | 965 |
|
|
2020
Q1 | $6.43M | Buy |
764,903
+244,478
| +47% | +$2.05M | ﹤0.01% | 1565 |
|
|
2019
Q4 | $5.08M | Buy |
520,425
+81,916
| +19% | +$800K | ﹤0.01% | 1987 |
|
|
2019
Q3 | $4.16M | Buy |
438,509
+164,828
| +60% | +$1.56M | ﹤0.01% | 2054 |
|
|
2019
Q2 | $3.25M | Buy |
+273,681
| New | +$3.25M | ﹤0.01% | 2212 |
|